Baird Financial Group, Inc. Paratek Pharmaceuticals, Inc. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.52 - $2.8 $38,098 - $70,182	-25,065 Reduced 70.61%	10,435 $23,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $10,917 - $16,320	5,570 Added 12.8%	49,070 $126,000
Q2 2022 Aug 08, 2022	SELL	$1.73 - $3.09 $2,897 - $5,175	-1,675 Reduced 3.71%	43,500 $84,000
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $1,617 - $2,623	550 Added 1.23%	45,175 $134,000
Q4 2021 Feb 09, 2022	SELL	$4.07 - $5.3 $24,013 - $31,270	-5,900 Reduced 11.68%	44,625 $200,000
Q3 2021 Nov 12, 2021	SELL	$4.7 - $7.24 $8,836 - $13,611	-1,880 Reduced 3.59%	50,525 $246,000
Q2 2021 Aug 11, 2021	BUY	$6.81 - $10.93 $3,405 - $5,465	500 Added 0.96%	52,405 $357,000
Q4 2020 Feb 11, 2021	SELL	$4.58 - $7.14 $8,702 - $13,566	-1,900 Reduced 3.53%	51,905 $325,000
Q3 2020 Nov 12, 2020	SELL	$4.19 - $6.69 $6,285 - $10,035	-1,500 Reduced 2.71%	53,805 $291,000
Q2 2020 Oct 22, 2020	BUY	$2.97 - $5.22 $12,474 - $21,924	4,200 Added 8.22%	55,305 $289,000
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $3,267 - $5,742	1,100 Added 2.2%	51,105 $206,000
Q1 2020 May 14, 2020	BUY	$2.67 - $4.97 $10,413 - $19,383	3,900 Added 8.46%	50,005 $158,000
Q4 2019 Feb 14, 2020	BUY	$2.93 - $4.5 $1,113 - $1,710	380 Added 0.83%	46,105 $186,000
Q3 2019 Nov 14, 2019	BUY	$3.08 - $5.76 $4,616 - $8,634	1,499 Added 3.39%	45,725 $198,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $15,469 - $28,174	4,458 Added 11.21%	44,226 $176,000
Q1 2019 May 14, 2019	SELL	$5.36 - $7.24 $582,975 - $787,451	-108,764 Reduced 73.23%	39,768 $213,000
Q4 2018 Feb 14, 2019	BUY	$4.8 - $11.6 $50,092 - $121,057	10,436 Added 7.56%	148,532 $762,000
Q3 2018 Nov 13, 2018	BUY	$9.05 - $10.95 $531,823 - $643,476	58,765 Added 74.08%	138,096 $1.34 Million
Q2 2018 Aug 13, 2018	BUY	$10.2 - $13.9 $809,176 - $1.1 Million	79,331 New	79,331 $809,000

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account